OncologyTube Professional - Patients Click Here
28,897 video views
Loading........
Description: Laura S. Wood, R.N., MSN, OCN, Cleveland Clinic Discusses Aimwithimmunotherapy.org And The Various Resources The Site Provides For Patients And Physicians.
05:36
Laura S. Wood, R.N., MSN, OCN, Cleveland Clinic Discusses Aimwithimmunoth​erapy.org And The Various Resources The Site Provides For Patients And Physicians.
by:Cancer-News | 99 views
01:33
Laura S. Wood, R.N., MSN, OCN, Cleveland Clinic Discusses Whats Next With Aimwithimmunoth​erapy.org. For More Info Visit: Aimwithimmunoth​erapy.org
by:Cancer-News | 112 views
02:14
Laura S. Wood, R.N., MSN, OCN, Cleveland Clinic Discusses Benefits Of Aimwithimmunoth​erapy.org And The Various Resources It Provides For Patients And Physicians. For More Info Visit: Aimwithimmunoth​erapy.org
by:Cancer-News | 103 views
01:15
Laura S. Wood, R.N., MSN, OCN, Cleveland Clinic Discusses Assessment & Education Regarding (irAEs). For More Info Visit: Aimwithimmunoth​erapy.org
by:Cancer-News | 128 views
01:27
Scott Fields, M.D., SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Bayer Xofigo Program. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
by:Cancer-News | 258 views
01:24
Scott Fields, M.D., SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Bayer Stivarga Program. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
by:Cancer-News | 215 views
01:16
Scott Fields, M.D., SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Bayer Regorafenib Program. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
by:Cancer-News | 167 views
01:27
Scott Fields, M.D., SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Bayer Copanlisib Program. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
by:Cancer-News | 164 views
02:03
Scott Fields, M.D., SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Bayer Larotrectinib Program. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
by:Cancer-News | 198 views
02:09
Do-Youn Oh, M.D., of Seoul National University Hospital discusses Treating Advanced Biliary Cancer: M7824 Data. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
by:Cancer-News | 101 views

About Cancer-News


Links
Channel Url: